191 related articles for article (PubMed ID: 26844275)
21. Association of Transforming Growth Factor β Polymorphism C-509T With Radiation-Induced Fibrosis Among Patients With Early-Stage Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Grossberg AJ; Lei X; Xu T; Shaitelman SF; Hoffman KE; Bloom ES; Stauder MC; Tereffe W; Schlembach PJ; Woodward WA; Buchholz TA; Smith BD
JAMA Oncol; 2018 Dec; 4(12):1751-1757. PubMed ID: 30027292
[TBL] [Abstract][Full Text] [Related]
22. The incidence of lung carcinoma after surgery for breast carcinoma with and without postoperative radiotherapy. Results of National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials B-04 and B-06.
Deutsch M; Land SR; Begovic M; Wieand HS; Wolmark N; Fisher B
Cancer; 2003 Oct; 98(7):1362-8. PubMed ID: 14508821
[TBL] [Abstract][Full Text] [Related]
23. 6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial.
Pivot X; Romieu G; Debled M; Pierga JY; Kerbrat P; Bachelot T; Lortholary A; Espié M; Fumoleau P; Serin D; Jacquin JP; Jouannaud C; Rios M; Abadie-Lacourtoisie S; Tubiana-Mathieu N; Cany L; Catala S; Khayat D; Pauporté I; Kramar A;
Lancet Oncol; 2013 Jul; 14(8):741-8. PubMed ID: 23764181
[TBL] [Abstract][Full Text] [Related]
24. Late toxicities and outcomes of adjuvant radiotherapy combined with concurrent bevacizumab in patients with triple-negative non-metastatic breast cancer.
Pernin V; Belin L; Cottu P; Bontemps P; Lemanski C; De La Lande B; Baumann P; Missohou F; Levy C; Peignaux K; Reynaud-Bougnoux A; Denis F; Gobillion A; Bollet M; Vago NA; Dendale R; Campana F; Fourquet A; Kirova YM
Br J Radiol; 2015 Apr; 88(1048):20140800. PubMed ID: 25645108
[TBL] [Abstract][Full Text] [Related]
25. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
Pass H; Vicini FA; Kestin LL; Goldstein NS; Decker D; Pettinga J; Ingold J; Benitez P; Neumann K; Rebner M; Dekhne N; Martinez A
Cancer; 2004 Aug; 101(4):713-20. PubMed ID: 15305400
[TBL] [Abstract][Full Text] [Related]
26. A phase I/II trial of intraoperative breast radiotherapy in an Asian population: 5-year results of local control and cosmetic outcome.
Kawamura M; Itoh Y; Sawaki M; Kikumori T; Tsunoda N; Kamomae T; Kubota S; Okada T; Nakahara R; Ito J; Hayashi H; Naganawa S
Radiat Oncol; 2015 Jul; 10():150. PubMed ID: 26205241
[TBL] [Abstract][Full Text] [Related]
27. Clinical and pathologic risk factors of tumor recurrence in patients with node-negative early breast cancer after mastectomy.
Lin PH; Yeh MH; Liu LC; Chen CJ; Tsui YC; Su CH; Wang HC; Liang JA; Chang HW; Wu HS; Yeh SP; Li LY; Chiu CF
J Surg Oncol; 2013 Nov; 108(6):352-7. PubMed ID: 23996583
[TBL] [Abstract][Full Text] [Related]
28. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial.
Vaidya JS; Joseph DJ; Tobias JS; Bulsara M; Wenz F; Saunders C; Alvarado M; Flyger HL; Massarut S; Eiermann W; Keshtgar M; Dewar J; Kraus-Tiefenbacher U; Sütterlin M; Esserman L; Holtveg HM; Roncadin M; Pigorsch S; Metaxas M; Falzon M; Matthews A; Corica T; Williams NR; Baum M
Lancet; 2010 Jul; 376(9735):91-102. PubMed ID: 20570343
[TBL] [Abstract][Full Text] [Related]
29. Increased heat shock protein 70 (Hsp70) serum levels and low NK cell counts after radiotherapy - potential markers for predicting breast cancer recurrence?
Rothammer A; Sage EK; Werner C; Combs SE; Multhoff G
Radiat Oncol; 2019 May; 14(1):78. PubMed ID: 31077235
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant breast radiotherapy using a simultaneous integrated boost: clinical and dosimetric perspectives.
Alford SL; Prassas GN; Vogelesang CR; Leggett HJ; Hamilton CS
J Med Imaging Radiat Oncol; 2013 Apr; 57(2):222-9. PubMed ID: 23551785
[TBL] [Abstract][Full Text] [Related]
31. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma.
Leong C; Boyages J; Jayasinghe UW; Bilous M; Ung O; Chua B; Salisbury E; Wong AY
Cancer; 2004 May; 100(9):1823-32. PubMed ID: 15112262
[TBL] [Abstract][Full Text] [Related]
32. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
33. Role of radiotherapy boost in women with ductal carcinoma in situ: a single-center experience in a series of 389 patients.
Meattini I; Livi L; Franceschini D; Saieva C; Meacci F; Marrazzo L; Bendinelli B; Scotti V; De Luca Cardillo C; Nori J; Sanchez L; Orzalesi L; Bonomo P; Greto D; Bucciolini M; Bianchi S; Biti G
Eur J Surg Oncol; 2013 Jun; 39(6):613-8. PubMed ID: 23523088
[TBL] [Abstract][Full Text] [Related]
34. [Evidence-based radiotherapy in the treatment of operable breast cancer: results in the 1990-ies].
Fodor J; Polgár C; Németh G
Orv Hetil; 2000 Jul; 141(28):1551-5. PubMed ID: 10957865
[TBL] [Abstract][Full Text] [Related]
35. Troponin T-release associates with cardiac radiation doses during adjuvant left-sided breast cancer radiotherapy.
Skyttä T; Tuohinen S; Boman E; Virtanen V; Raatikainen P; Kellokumpu-Lehtinen PL
Radiat Oncol; 2015 Jul; 10():141. PubMed ID: 26159409
[TBL] [Abstract][Full Text] [Related]
36. Concurrent cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy and radiotherapy for early breast carcinoma.
Livi L; Saieva C; Borghesi S; Paoletti L; Meattini I; Rampini A; Petrucci A; Scoccianti S; Paiar F; Cataliotti L; Leonulli BG; Bianchi S; Biti GP
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):705-9. PubMed ID: 18191333
[TBL] [Abstract][Full Text] [Related]
37. Predictive factors for late normal tissue complications following radiotherapy for breast cancer.
Lilla C; Ambrosone CB; Kropp S; Helmbold I; Schmezer P; von Fournier D; Haase W; Sautter-Bihl ML; Wenz F; Chang-Claude J
Breast Cancer Res Treat; 2007 Nov; 106(1):143-50. PubMed ID: 17221151
[TBL] [Abstract][Full Text] [Related]
38. Early detection and prediction of cardiotoxicity after radiation therapy for breast cancer: the BACCARAT prospective cohort study.
Jacob S; Pathak A; Franck D; Latorzeff I; Jimenez G; Fondard O; Lapeyre M; Colombier D; Bruguiere E; Lairez O; Fontenel B; Milliat F; Tamarat R; Broggio D; Derreumaux S; Ducassou M; Ferrières J; Laurier D; Benderitter M; Bernier MO
Radiat Oncol; 2016 Apr; 11():54. PubMed ID: 27056179
[TBL] [Abstract][Full Text] [Related]
39. Is axillary lymph node dissection necessary after sentinel lymph node biopsy in patients with mastectomy and pathological N1 breast cancer?
Fu Y; Chung D; Cao MA; Apple S; Chang H
Ann Surg Oncol; 2014 Dec; 21(13):4109-23. PubMed ID: 25081336
[TBL] [Abstract][Full Text] [Related]
40. Interval between breast-conserving surgery and start of radiation therapy in early-stage breast cancer is not predictive of local recurrence: a single-institution experience.
Barbieri V; Sanpaolo P; Genovesi D
Clin Breast Cancer; 2011 Apr; 11(2):114-20. PubMed ID: 21569997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
